Radboud University Medical Center
π³π±Netherlands
- Country
- π³π±Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
A Clinical Practice Snapshot on Pediatric Kidney Transplantation
Completed
- Conditions
- Kidney Transplant Failure
- First Posted Date
- 2022-11-17
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 410
- Registration Number
- NCT05619679
- Locations
- π³π±
Radboud University Medical Center, Nijmegen, Netherlands
He-move-philia, Lifestyle Intervention for Patients With Hemophilia
Not Applicable
Active, not recruiting
- Conditions
- Hemophilia
- Interventions
- Other: Lifestyle - group sessionsOther: Lifestyle - individual coaching
- First Posted Date
- 2022-11-08
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05608863
- Locations
- π³π±
RadboudUMC, Nijmegen, Gelderland, Netherlands
MRI-guided Holmium-166 Radioembolization
Not Applicable
- Conditions
- Non-Resectable Hepatocellular CarcinomaPrimary Liver Cancer
- Interventions
- Procedure: MRI-guided radioembolization
- First Posted Date
- 2022-11-08
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT05609448
- Locations
- π³π±
RadboudUMC, Nijmegen, Netherlands
The GATE Study: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device
Phase 2
Not yet recruiting
- Conditions
- Diabete Type 2Obesity
- Interventions
- Device: Endoscopic sutured gastroplasty with endomina
- First Posted Date
- 2022-10-31
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT05599477
Super-resolution of Brain Magnetic Resonance Images in Deep Brain Stimulation for Parkinson's Disease
- Conditions
- Parkinson DiseaseParkinson
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT05596201
- Locations
- π³π±
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
Oral Complications After Haematopoietic Stem Cell Transplantation: a Retrospective Study
- Conditions
- Oral ComplicationStem Cell Transplant Complications
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT05595070
- Locations
- π³π±
Radboudumc, Nijmegen, Netherlands
The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells
Not Applicable
Completed
- Conditions
- Sepsis, Endotoxemia, Immunosuppression
- Interventions
- Drug: PlaceboDrug: LPS
- First Posted Date
- 2022-10-06
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT05570643
- Locations
- π³π±
Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Impact of Deep Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recovery and Immune Function
Phase 4
Recruiting
- Conditions
- Quality of LifePostoperative ComplicationsNeuromuscular BlockadeInnate Inflammatory Response
- Interventions
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT05562999
- Locations
- π³π±
Radboudumc, Nijmegen, Netherlands
AADC/TDC in Advanced Parkinson's Disease
Completed
- Conditions
- Parkinson Disease
- First Posted Date
- 2022-09-28
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 48
- Registration Number
- NCT05558787
- Locations
- π³π±
Radboudumc Centre of Expertise for Parkinson & Movement Disorders, Nijmegen, Netherlands
Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC
Not Applicable
Recruiting
- Conditions
- Early-stage Lung Cancer
- Interventions
- Radiation: 99mTc-nanocolloidDrug: ICG
- First Posted Date
- 2022-09-26
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT05555199
- Locations
- π³π±
Radboudumc, Nijmegen, Gelderland, Netherlands
Β© Copyright 2025. All Rights Reserved by MedPath